[Federal Register Volume 62, Number 18 (Tuesday, January 28, 1997)]
[Notices]
[Page 4072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-2061]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Cancer Institute; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Cancer Institute Special Emphasis Panel (SEP) meetings:
Purpose/Agenda: To evaluate and review grant applications.
Name of SEP: Cancer Therapy with Activated Natural Killer Cells.
Date: February 10, 1997.
Time: 1 p.m.
Place: Teleconference, Executive Plaza North, Room 635E, 6130
Executive Boulevard, Bethesda, MD 20892.
Contact Person: David Irwin, PH.D., Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 635E, 6130 Executive Boulevard, MSC 7405, Bethesda, MD
20892-7405, telephone: 301/402-0371.
This notice is being published less than 15 days prior to the above
meetings due to the urgent need to meet timing limitations imposed by
the grant review and funding cycle.
Name of SEP: Cancer Prevention and Control Research Small Grant
Program.
Date: February 19, 1997.
Time: 1 p.m.
Place: Teleconference, Executive Plaza North, Room 611, 6130
Executive Boulevard, Bethesda, MD 20892.
Contact Person: Kevin T. Ryder, Ph.D., Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 611, 6130 Executive Boulevard, MSC 7405, Bethesda, MD
20892-7405, telephone: 301/496-2785.
Name of SEP: Bone Marrow Transplantation in Human Disease Review
Panel.
Date: February 27, 1997.
Time: 1 p.m.
Place: Teleconference, Executive Plaza North, Room 643H, 6130
Executive Boulevard, Bethesda, MD 20892.
Contact Person: Judy Mietz, Ph.D., Scientific Review
Administrator, National Cancer Institute, NIH, Executive Plaza
North, Room 643H, 6130 Executive Boulevard, MSC 7405, Bethesda, MD
20892-7405, telephone: 301/496-2378.
The meetings will be closed in accordance with the provisions set
forth in secs. 552(c)(4) and 552(c)(6), Title 5, U.S.C. Applications
and/or proposals and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and personal
information concerning individuals associated with the applications
and/or proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Nos. 93.393, Cancer
Cause and Prevention Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93.399, Cancer Control.)
Dated: January 22, 1997.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 97-2061 Filed 1-27-97; 8:45 am]
BILLING CODE 4140-01-M
